Silk Brown Rice Protein Powder - Organic

Back of the bag image of Silk Brown Rice Protein Powder - Organic 1 lb

Front bag image of Silk Brown Rice Protein Powder - Organic 5 lb

Back of the bag image of Silk Brown Rice Protein Powder - Organic 5 lb

Brown Rice in wooden bowl piled together on white background

Silk Brown Rice Protein Powder - Organic

Pay now$16.99~~$20.00~~

Purchase Options

One Time Purchase $16.99

Subscribe & save

$15.29

Frequently Bought together

Total price: $

About Product

Organic Silk Brown Rice Protein Powder is a great way to add a delicious, nutritious boost to your diet.

This all-natural, vegan-friendly protein powder is made from organic brown rice and contains no added sugar or artificial ingredients. It’s a source of essential amino acids to help you meet your daily nutritional needs.

Its delicious flavor makes it a perfect addition to smoothies, shakes, and other recipes.

With its clean, natural flavor, you can enjoy the health benefits of this protein powder without sacrificing taste. Plus, it’s gluten-free, dairy-free, and non-GMO, providing an excellent alternative for those with dietary restrictions.

Suggested Use: Mix 3.5 level tablespoons / 1 ounce (28 grams ) with 12 ounces of cold water, skim milk, or juice and thoroughly mix in a blender, shaker, or spoon for 20-30 seconds. For best results, consume 1-2 servings daily, with one serving post-exercise. It can also be blended into your favorite smoothie.
Mixing Suggestions: To increase flavor and nutritional profile, combined with our organic blueberry, strawberry, and raspberry powders.

Miscellaneous Facts about our Organic Brown Rice Protein

Certifications: Certified USDA Organic.
Ingredients: Organic Sprouted Brown Rice Protein.
Parts Used: Brown Rice.
Origin: Grown and extracted in China and packaged with care in Florida, USA.

1. Anderhuber, R. 1991. Vaccinium myrtillus . Aust J Med Herbalism 3:13"“14

2. Azar, M., E. Verette, S. Brun. 1987. Identification of some phenolic compounds in bilberry juice Vaccinium myrtillus. J Food Sci 52(5):1255"“1257

3. Barrette, E.P. 1999. Bilberry fruit extract for night vision. Alternative Medicine Alert™ 2(2):20"“21

4. Bone, K. and M. Morgan. 1997. Bilberry"”The Vision Herb. MediHerb Professional Review 59:1"“4

5. Braun, R. et al. 1997. Standardzulassungen fÃ¼r Fertigarzneimittel"”Text and Kommentar. Stuttgart: Deutscher Apotheker Verlag.

6. Bravetti, G. 1989. Preventive medical treatment of senile cataract with vitamin E and anthocyanosides: clinical evaluation. Ann Ottalmol Clin Ocul 115:109

7.Bruneton, J. 1995. Pharmacognosy, Phytochemistry, Medicinal Plants. Paris: Lavoisier Publishing

8. Bundesanzeiger (BAnz). 1998. Monographien der Kommission E (Zulassungs- und Aufbereitungskommission am BGA fÃ¼r den humanmed. Bereich, phytotherapeutische Therapierichtung und Stoffgruppe). KÃ¶ln: Bundesgesundheitsamt (BGA)

9. Caselli, L. 1985. Studio clinico ed elettroretinografico sull'attivita degli antocianosidi [Clinical and electroretinographic study on activity of anthocyanosides]. Arch Med Int (Parma) 37:29"“35

10. Cluzel, C., P. Bastide, P. Tronche. 1969. [Phosphoglucomutase and glucose-6-phosphatase activities of the retina and anthocyanoside extracts from Vaccinium myrtillus (study in vitro and in vivo )] [In French]. C R Seances Soc Biol Fil 163(1):147"“150

11. Colantuoni, A., S. Bertuglia, M.J. Magistretti, L. Donato. 1991. Effects of Vaccinium myrtillus anthocyanosides on arterial vasomation. Arzneimforsch 41(9):905"“909.

12. Cunio, L. 1993. Vaccinium myrtillus . Aust J Med Herbalism 5(4):81"“85

13. Deutscher Arzneimittel-Codex (DAC). 1986. Stuttgart: Deutscher Apotheker Verlag

14. Ferretti, C., M.J. Magistretti, A. Robotti, P. Ghi, E. Genazzani. 1988. Vaccinium myrtillus anthocyanosides are inhibitors of cAMP and cGMP phosphodiesterases. Pharm Res Comm 20(11):150

15. Fiorini, G., A. Biancacci, F.M. Graziano. 1965. Modificazioni perimetriche ed adattometriche dopo ingestione di mirtillina associata a beta-carotene [Perimetric and adaptometric modifications after ingestion of myrtillin associated with beta-carotene]. Ann Ottalmol Clin Ocul 91(6):371"“386

16. Foster, S. 1996. Bilberry: A Long History. Health Food Business. August 1996: 40

17. Friedrich, V.H. and J. SchÃ¶nert. 1973. Untersuchungen Ã¼ber einige Inhaltsstoffe der BlÃ¤tter und FrÃ¼chte von Vaccinium myrtillus [Phytochemical investigation of leaves and fruits of Vaccinium myrtillus ]. Planta Med 24(1):90"“100

18. German Homeopathic Pharmacopoeia (GHP). 1993. Translation of the Deutsches HomÃ¶opathisches Arzneibuch (HAB 1), 1st ed., 5th suppl. 1991. Stuttgart: Deutscher Apotheker Verlag. 383"“384

19. Ghiringhelli, C., F. Gregoratti, F. Marastoni. 1978. Attivita capillarotrop di antocianosidi and alto dosaggio nella stasi da flebopatia [Capillarotropic activity of anthocyanosides in high doses in phlebopathic statis]. Minerva Cardioangiol 26(4):255"“276

20. Grieve, M. 1979. A Modern Herbal. New York: Dover Publications, Inc.

21. HÃ¤nsel, R., K. Keller, H. Rimpler, G. Schneider (eds.). 1992"“1994. Hagers Handbuch der Pharmazeutischen Praxis, 5th ed. Vol. 4"“6. Berlin-Heidelberg: Springer Verlag

22. Jayle, G.E. and L. Aubert. 1964. [Action des glucosides d'anthocyanes sur la vision scotopique et mesopique du sujet normal] [In French]. Therapie 19:171

23. Jayle, G.E. et al. 1965. [Study concerning the action of anthocyanoside extracts of Vaccinium Myrtillus on night vision] [In French]. Ann Ocul (Paris) 198(6):556"“562

24. Lagrue, G. et al. 1979. Pathology of the microcirculation in diabetes and alterations of the biosynthesis of intracellular matrix molecules. Front Matrix Biol S Karger 7:324"“325

25. Leung, A.Y. and S. Foster. 1996. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics, 2nd ed. New York: John Wiley & Sons, Inc. 84"“85

26. Lietti, A., A. Cristoni, M. Picci. 1976. Studies on Vaccinium myrtillus anthocyanosides. I. Vasoprotective and antiinflammatory activity. Arzneimforsch 26(5):829"“832

27. Meyer-Buchtela, E. 1999. Tee-Rezepturen"”Ein Handbuch fÃ¼r Apotheker und Ã„rzte. Stuttgart: Deutscher Apotheker Verlag

28. Morazzoni, P. and E. Bombardelli. 1996. Vaccinium myrtillus L. Fitoterapia 67(1):3"“29

29. Neumann, L. 1971. Therapeutische Versuche mit Anthozyanosiden bei Langzeitbehandlungen in der Augenheilkunde [In German]. Klin Monatsbl Augenheilkd 158:592"“597

30. Ã–sterreichisches Arzneibuch, 1st suppl. (Ã–AB). 1983. Wien: Verlag der Ã–sterreichischen Staatsdruckerei

31. Ã–sterreichisches Arzneibuch (Ã–AB). 1991. Wien: Verlag der Ã–sterreichischen Staatsdruckerei

32. Pennarola, R. et al. 1980. The therapeutic action of the anthocyanosides in microcirculatory changes due to adhesive-induced polyneuritis. Gazz Med Ital 139:485"“491

33. Perossini, M. et al. 1987. Diabetic and hypertensive retinopathy therapy with Vaccinium myrtillus anthocyanosides (Tegens): Double blind placebo controlled clinical trial. Ann Ottalmol Clin Ocul 113:1173

34. Pharmacopoeia Helvetica, 7th ed. Vol. 1"“4. (Ph.Helv.VII). 1987. Bern: Office Central FÃ©dÃ©ral des ImprimÃ©s et du MatÃ©riel

35. Pizzorno, J.E. and M.T. Murray. 1992. A Textbook of Natural Medicine. Seattle, WA: Bastyr University Publications

36. Politzer, M. 1977. [Experiences in the medical treatment of progressive myopia] [In German]. Klin Monatsbl Augenheilkd 171(4):616"“619